Home
About Us
Background
Investment Strategy
Team
Portfolio
News
Contact
中文
Investor Login
Home
About Us
Background
Investment Strategy
Team
Portfolio
News
Contact
中文
Investor Login
We are Company Builders
Identifying, incubating and growing future industry leaders in life sciences.
We are Industry Veterans
Capturing evolving healthcare trends and emerging cutting-edge innovations
We are Preferred Partners
Connecting companies with extensive network and resources globally and in China
Sail Biomedicines Appoints Clinical and Scientific Leader Dr. Wendy Chung to Its Board
...
May 15, 2024
Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
...
May 15, 2024
Zenas BioPharma Announces Upsized $200 Million Series C Financing to Advance Mid- and Late-Stage Immunology-Focused Clinical Development Programs
...
May 7, 2024
All news